SCHEMBL6255751

SCHEMBL6255751

O=C(NCCc1ccccc1)NCC(O)COc1ccc(Cl)cc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.61
KMT2A Q03164 5/20 0.61
TAAR1 Q96RJ0 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
ABCB1 P08183 1/20 0.56
MAPT P10636 1/20 0.56
MAPK1 P28482 1/20 0.56
ADAMTS5 Q9UNA0 2/20 0.55
NPC1 O15118 1/20 0.54
CNR1 P21554 1/20 0.54
RAB9A P51151 1/20 0.54
ADRB1 P08588 5/20 0.53
ADRB3 P13945 4/20 0.53
ADRB2 P07550 2/20 0.53
KCNH2 Q12809 1/20 0.52
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6322809 0.91 ADRB1 (0.61) MEN1KMT2ATAAR1ABCB1MAPK1
SCHEMBL6255835 0.88 ABCB1 (0.56) MEN1KMT2ASMN1; SMN2ABCB1MAPT
SCHEMBL6258143 0.88 CASR (0.58) MEN1KMT2ATAAR1ABCB1MAPT
SCHEMBL6260126 0.86 ABCB1 (0.59) MEN1KMT2ASMN1; SMN2ABCB1MAPT
SCHEMBL6259862 0.86 ABCB1 (0.58) ABCB1MAPTMAPK1ADRB1ADRB3
SCHEMBL6256734 0.85 MEN1 (0.58) MEN1KMT2ASMN1; SMN2ABCB1MAPT
SCHEMBL6257529 0.84 MEN1 (0.62) MEN1KMT2ASMN1; SMN2ABCB1MAPT
SCHEMBL6260399 0.84 ADRB1 (0.64) MEN1KMT2AABCB1MAPTMAPK1
SCHEMBL6260086 0.81 KDM4E (0.57) KMT2AABCB1MAPTMAPK1ADRB1
SCHEMBL8149545 0.79 MEN1 (0.67) MEN1KMT2ASMN1; SMN2MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962945-B2 N-aryloxypropanolyl-N′-phenethyl-urea COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-11-08 US claimed
US-20050215631-A1 NOVEL N-ARYLOXYPROPANOLYL-N' - PHENETHYL - UREA COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-09-29 US claimed
US-6962945-B2 N-aryloxypropanolyl-N′-phenethyl-urea COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-11-08 US disclosed
US-20050215631-A1 NOVEL N-ARYLOXYPROPANOLYL-N' - PHENETHYL - UREA COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2005-09-29 US disclosed
WO-2005063699-A1 N-ARYLOXYPROPANOLYL-N’-PHENETHYL-UREA COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2005-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215631-A1 NOVEL N-ARYLOXYPROPANOLYL-N' - PHENETHYL - UREA NPY4R, GPR119, MC4R MEN1 3594/4885KMT2A 1285/4885TAAR1 215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.